Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.66 |
| ▸ | ALPI | P09923 | 1/20 | 0.66 |
| ▸ | PKM | P14618 | 1/20 | 0.66 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.66 |
| ▸ | XIAP | P98170 | 1/20 | 0.66 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.56 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.55 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.51 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.51 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | CTSC | P53634 | 1/20 | 0.47 |
| ▸ | ANPEP | P15144 | 1/20 | 0.47 |
| ▸ | LAP3 | P28838 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5968413 | 1.00 | SLC7A5 (0.66) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL27632375 | 1.00 | SLC7A5 (0.66) | SLC7A5ALPIPKMPTGS1XIAP | |
| Hydrochloric Acid SCHEMBL27297692 | 0.98 | ALPI (0.63) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL28660345 | 0.98 | SLC7A5 (0.63) | SLC7A5ALPIPKMPTGS1XIAP | |
| Carbamic Acid SCHEMBL27955343 | 0.96 | ALPI (0.61) | SLC7A5ALPIPKMPTGS1XIAP | |
| Nitrous Acid SCHEMBL28206840 | 0.93 | ALPI (0.58) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL28820471 | 0.90 | SLC7A5 (0.68) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL8835936 | 0.90 | SLC7A5 (0.68) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL288607 | 0.90 | SLC7A5 (0.68) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL29160724 | 0.89 | SLC7A5 (0.66) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1426 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119776360-A | GPIHBP1 mutant gene and application thereof | 中国人民解放军东部战区总医院 | 2025-04-08 | — | — | CN | claimed |
| CN-119410679-A | Method for optimizing antibody expression | AMBRX公司 | 2025-02-11 | — | — | CN | claimed |
| CN-119410678-A | Method for optimizing antibody expression | AMBRX公司 | 2025-02-11 | — | — | CN | claimed |
| CN-112313336-B | Method for optimizing antibody expression | AMBRX公司 | 2024-12-03 | — | — | CN | claimed |
| WO-2024138897-A1 | NANOBODY TARGETING BCMA, CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF | 河北森朗生物科技有限公司 | 2024-07-04 | — | — | WO | claimed |
| CN-220940939-U | Smashing device for processing phenylalaninol | 东港市宏达制药有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-117924503-A | Humanized anti-Prostate Specific Membrane Antigen (PSMA) antibody drug conjugates | AMBRX公司 | 2024-04-26 | — | — | CN | claimed |
| EP-4353829-A1 | METHOD FOR QUANTIFYING PHENYLALANINE IN BLOOD, AND MEASUREMENT KIT USED THEREFOR | Renascience Inc. (JP) | 2024-04-17 | — | — | EP | claimed |
| CN-220780274-U | Hydrolysis equipment for production of phenylalaninol | 东港市宏达制药有限公司 | 2024-04-16 | — | — | CN | claimed |
| WO-2024016658-A1 | PAL VARIANT, PHARMACEUTICAL COMPOSITION CONTAINING PAL VARIANT, AND METHOD FOR PREPARING PAL VARIANT | 浙江泽科塔生物医药有限公司 | 2024-01-25 | — | — | WO | claimed |
| EP-1693380-B1 | Nucleic acid sequence encoding the OPCA gene | PAIK KWANG IND CO LTD (KR) | 2009-04-22 | — | — | EP | claimed |
| CN-101223272-A | Expanding the eukaryotic genetic code | SCRIPPS RESEARCH INST (US) | 2008-07-16 | — | — | CN | claimed |
| CN-1159017-C | Antimony halide medicine composition for treating leukemia and lymphoma | 苏州市第二人民医院 | 2004-07-28 | — | — | CN | claimed |
| US-6667039-B1 | Delivering therapeutic agent to CD30+ malignant cells by contacting with conjugate comprising one or more agents attached to soluble CD30 ligand polypeptide having specified amino acid sequence | IMMUNEX CORPORATION | 2003-12-23 | — | — | US | claimed |
| CN-1385167-A | Antimony halide medicine composition for treating leukemia and lymphoma | SUZHOU NO 2 RENMIN HOSPITAL (CN) | 2002-12-18 | — | — | CN | claimed |
| US-6004930-A | ADMINISTERING GAMMA ZEIN PROTEIN WITH PHENYLALANINE AMINO ACIDS REMOVED; PHENYLKETONURIA TREATMENT; ELIMINATED CODONS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION | 1999-12-21 | — | — | US | claimed |
| EP-0534568-B1 | Human growth hormone analogues and their use | ENIRICERCHE SPA (IT) | 1996-05-15 | — | — | EP | claimed |
| EP-0578909-B1 | Human prohibitin and DNA coding for the same | CANCER INST (JP) | 1996-04-17 | — | — | EP | claimed |
| EP-0197784-A1 | Method for immobilizing a biological material | GENEX CORPORATION (US) | 1986-10-15 | — | — | EP | claimed |
| US-4504582-A | Vermiculite as a carrier support for immobilized biological materials | GENEX CORPORATION (US) | 1985-03-12 | — | — | US | claimed |